Lv0
0 积分 2022-12-15 加入
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
4小时前
待确认
Niraparib as a therapeutic agent for the treatment of ovarian cancer meningeal dissemination with BRCA1 mutation
1年前
已完结
Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors
2年前
已完结
PARPi用于初治卵巢上皮性癌患者一线维持治疗的真实世界临床数据分析
2年前
已完结
Combining PARP Inhibitor With Immunotherapy—Does the Promise of Preclinical Data Translate to Clinic?
2年前
已完结
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
2年前
已完结
皖公网安备34019202002308
